Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InsiderLaura McDuffie
This page shows the track record and history of McDuffie Laura insider trades in Pediatrix Medical Group, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Laura McDuffie in MD / Pediatrix Medical Group, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MD / Pediatrix Medical Group, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Laura McDuffie in MD / Pediatrix Medical Group, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-11-06 10,000 21.6500 10,000 21.6500 216,500 106 18.8200 -28,300 -13.07
2024-08-27 7,000 11.1600 7,000 11.1600 78,120

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MD / Pediatrix Medical Group, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-11 2026-05-07 4 McDuffie Laura MD Common Stock A - Award D 7,196 39,428
2025-11-10 2025-11-06 4 McDuffie Laura MD Common Stock S - Sale D 21.6500 -10,000 -216 32,232
2025-05-12 2025-05-08 4 McDuffie Laura MD Common Stock A - Award D 11,427 42,232
2024-08-29 2024-08-27 4 McDuffie Laura MD Common Stock S - Sale D 11.1600 -7,000 -78 30,805
2024-05-13 2024-05-09 4 McDuffie Laura MD Common Stock A - Award D 18,360 37,805
2023-05-15 2023-05-11 4 McDuffie Laura MD Common Stock A - Award D 10,965 19,445
2022-05-13 2022-05-12 4 McDuffie Laura MD Common Stock A - Award D -8,480 8,480
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)